Mistras Theodora — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Mistras Theodora has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Theodora Mistras is the Chief Financial Officer of Viatris Inc., a global pharmaceutical company formed in 2020 from the merger of Upjohn (Pfizer) and Mylan. The most recent SEC filing dated 2026-01-02 lists her as CFO with zero reported insider purchases or sales for Viatris.
Role
CVP, Chief Financial Officer
Notability
40/100
Board memberships
Viatris Inc.
Awards & honors
Leading financial strategy and reporting as CFO for a global pharma company
Overseeing capital structure and treasury operations for Viatris post-merger
Guiding financial governance and compliance during rapid corporate integration
Theodora Mistras is the Chief Financial Officer of Viatris Inc., a global pharmaceutical company formed in 2020 from the merger of Upjohn (Pfizer) and Mylan. The most recent SEC filing dated 2026-01-02 lists her as CFO with zero reported insider purchases or sales for Viatris.…
How many SEC Form 4 filings has Mistras Theodora submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Mistras Theodora's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
